发明名称 Electrocardiographic aspects of chf treatment
摘要 In accordance with the present invention, it has been found that prolonged QT-c intervals in mammalian patients, indicative of susceptibility of the patients to arrhythmia and sudden cardiac death, can be reduced by a process in which an aliquot of the patient's blood is removed and stressed extracorporeally, by application thereto of oxidative stress and electromagnetic radiation such as ultraviolet light, and then re-injected into the patient. Such treatment results in a significant reduction in QT-c interval in the patients, indicative of reduced susceptibility to arrhythmia and sudden cardiac death. In clinical trials described in the Examples section below, this reduction in QT-c interval was associated with a marked reduction in sudden cardiac death. There are also indications that, in the absence of treatment according to the invention, the patients would have exhibited a lengthening of their QT-c intervals.
申请公布号 US2005244298(A1) 申请公布日期 2005.11.03
申请号 US20050510594 申请日期 2005.05.24
申请人 SMITH ELDON R;TORRE-AMIONE GUILLERMO 发明人 SMITH ELDON R.;TORRE-AMIONE GUILLERMO
分类号 A61K35/14;A61K41/00;A61M1/36;A61N5/00;A61P9/04;A61P9/06;(IPC1-7):A61M1/14 主分类号 A61K35/14
代理机构 代理人
主权项
地址